Pharmacogenomics and Bioinformatics Specialist | Advocate for Precision Medicine in Oncology:
Dr. Hina Ahsan having expertise of molecular biostatistics, cancer genetics, and computational oncology. Her expertise spans expression profiling, proteomic and transcriptomic analysis, spatial genomics, and in silico drug design, with a strong command of R, Python, and AI driven analytical frameworks.
She focuses on decoding complex genomic datasets to study tumor evolution, heterogeneity, and drug resistance mechanisms, integrating machine learning and artificial intelligence to advance precision medicine. Her research contributes to developing personalized therapeutic strategies through multi omics modeling and computational prediction.
Dr. Hina Ahsan is also an editor and reviewer for international scientific journals and has authored high impact publications in cancer biology, genomics, and AI enabled biomedical research. Known for her interdisciplinary collaboration, scientific rigor, and commitment to healthcare innovation, she actively contributes to clinical genomics, community based health projects, and translational research.
Her work reflects a strong dedication to improving patient outcomes by bridging molecular biology, biostatistics, and artificial intelligence within modern clinical and research environments.